Antibiotics market growth prospects and present scenario of the global market for 2017-2021. And in-depth antibiotics market analysis report.
An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term "antibiotic" was originally coined to refer to any compound of microbial origin that is antagonistic to the growth of the microbe.
Read about antibiotics market at www.reportsnreports.com/reports/11…et-2017-2021.html
The analysts forecast global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021. The latest trend gaining momentum in the market is Strategic alliances and mergers and acquisitions (M&A).
Formation of strategic alliances, in terms of licensing and collaboration, help in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertize from both companies.
Ask for Report at www.reportsnreports.com/contacts/d…aspx?name=1187089 .
According to the antibiotics market report, one of the major drivers for this market is Rising prevalence of infectious diseases. Globally, there has been an increase in the number individuals affected by infectious diseases.
Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases.
Demographic changes caused by increased globalization and urbanization are a major factor leading to the global emergence of infectious diseases.
Get a Copy of antibiotics market Report www.reportsnreports.com/purchase.aspx?name=1187089 .
Key players in the global antibiotics market: Allergan, GlaxoSmithKline, Merck, and Pfizer. Other Prominent Vendors in the market are: Abbott, Achaogen, Actelion Pharmaceuticals, AmpliPhi Biosciences, Aspen Pharmacare, Astellas Pharma, AstraZeneca, Aurobindo Pharma, Baxter, Basilea Pharmaceutica, Bayer HealthCare, Biocon, Bristol-Myers Squibb, Cempra, Cipher Pharmaceuticals, CordenPharma, Chiesi Farmaceutici, Eli Lilly, Exoxemis, F.
Hoffmann-La Roche, Flynn Pharma, Incepta Pharmaceuticals, InSite Vision, Insmed, Johnson & Johnson, Humanigen, Kyorin Pharmaceutical, Lupin Pharmaceuticals, Lytix Biopharma, Melinta Therapeutics, Mylan, Nektar, Orchid Pharma, Par Pharmaceutical, Paratek Pharmaceuticals, Pernix Therapeutics, PTC Therapeutics, RedHill, Sagent Pharmaceuticals, Sanofi, Shionogi, Starpharma, Sun Pharmaceutical, Symbiomix, Takeda Pharmaceutical, Tetraphase Pharmaceuticals, Theravance Biopharma, The Medicines Company, Valneva, and Wockhardt.
Further, the report states that one of the major factors hindering the growth of this market is Development of antibiotic-resistant strains. The development of multidrug-resistant microbes is one of the major threats to the human health in the present days.
The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. The antibiotic resistance usually develops due to the irrational use of these drugs.
This report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
The report also includes a discussion of the key vendors operating in this market.
The market is divided into the following segments based on geography:
List of Exhibits
Exhibit 01: Overview of mechanism of action of antibiotics
Exhibit 02: Mechanism of action of antibiotics
Exhibit 03: General principles involved in the use of antibiotics
Exhibit 04: Clinical use of antibiotics for treatment of various common infections
Exhibit 05: Types of HAIs 2016
Exhibit 06: Causes of antibiotic resistance
Exhibit 07: Transfer of antibiotic-resistant strain
Exhibit 08: Development of antibiotic resistance
Exhibit 09: Spread of antibiotic resistance
Exhibit 10: Antibiotic resistance scenario in the US
Exhibit 11: Initiatives to facilitate antibiotic development
Exhibit 12: Global antibiotics market snapshot and more.